Website review
This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.
What is Synvisc-One?
Synvisc-One is a single-injection treatment for knee osteoarthritis (OA) pain. Its active ingredient is hylan G-F 20, a form of hyaluronic acid used as a viscosupplement: it is injected into the knee joint to supplement the synovial fluid that cushions and lubricates the joint. According to the official site, one injection may provide up to six months of pain relief.
Who it is for
- Adults with knee OA whose pain has not responded adequately to non-drug measures such as exercise and weight management, or to simple pain relievers.
- People seeking a lower-frequency option than treatments requiring repeated visits.
Practical points
- It is given by a healthcare professional, typically in a clinic setting.
- It is not a cure for osteoarthritis and does not reverse cartilage damage.
- Because it is a single dose, the convenience trade-off is that relief depends on one injection rather than a series.
- Suitability depends on individual medical history; a clinician assesses whether it is appropriate.
More details, including safety information, are available at Synvisc-One® Official Site.
How does Synvisc-One work to relieve knee pain?
Synvisc-One is a single-injection treatment for osteoarthritis (OA) knee pain. Its active substance, hylan G-F 20, is a gel-like form of hyaluronic acid, a substance naturally present in joint fluid. In an OA knee, that fluid becomes thinner, so the joint has less cushioning and lubrication. The injection is intended to supplement the joint fluid, which may help restore some of that cushioning and support smoother movement, reducing pain signals associated with bone-on-bone friction.
What to expect
- A healthcare provider administers it as one injection into the knee.
- The official site describes relief lasting up to six months for some patients.
- It is used for knee OA, not for other joints or for non-OA knee pain.
- Response varies; some people get little or no benefit.
Who it may suit
It is typically considered for people with knee OA who have not found enough relief from non-drug measures such as exercise and weight management, or from simple pain relievers, and who prefer an interval treatment over daily medication. It is not a cure, and it does not reverse cartilage damage.
Trade-offs
A single injection is convenient compared with multi-injection courses, but it is an in-office procedure with possible side effects such as temporary knee pain, swelling or stiffness. Because individual results differ, discussing candidacy, alternatives and expectations with a clinician is essential. More detail is available at Synvisc-One® Official Site.
How long does Synvisc-One provide pain relief?
According to the official site, Synvisc-One (hylan G-F 20) is described as providing up to six months of osteoarthritis knee pain relief from a single injection. That is the headline duration the manufacturer promotes, and it is the figure most relevant to people comparing it with other knee OA options.
A few practical points follow from that claim:
- Single-injection format. The appeal is convenience: one injection rather than a series of visits, which may suit people who want less frequent clinic time.
- "Up to" is a ceiling, not a guarantee. Individual results vary; some people may get relief for a shorter period, and the site does not promise a fixed duration for everyone.
- Relief is for knee OA symptoms. It is a viscosupplementation treatment, not a cure for osteoarthritis, and it is intended for knee pain rather than other joints.
For context, the same manufacturer also offers a multi-injection version of the product, typically given as a course of injections. The trade-off is more visits versus a different dosing schedule.
Because duration, suitability and side effects depend on your knee and history, the official page is best used to understand the treatment and prepare questions for a clinician. The manufacturer's site is Synvisc-One® Official Site.
Is Synvisc-One FDA-approved and what are its side effects?
Synvisc-One is a single-injection treatment for osteoarthritis knee pain, and the official site presents it as an option that may provide up to six months of relief. It is a prescription product, so eligibility and appropriateness are determined by a clinician rather than by the website.
H3 Regulatory status The product is described on its official site as an FDA-approved treatment. Approval applies to the specific indication and formulation; it does not mean the treatment is right for every person with knee pain, and it is not a cure for osteoarthritis.
H3 Side effects As with any injection into the knee, side effects can occur. Commonly discussed reactions include:
- Pain, swelling, warmth or stiffness at the injection site
- Redness or fluid accumulation around the knee
- Headache or back pain
Less common but more serious reactions may include severe joint swelling or inflammation, infection, or allergic reactions. Some people experience a reaction after a repeat injection. Because risks vary with medical history and other treatments, the official site and the prescribing information are the appropriate places to review warnings, and a clinician can explain how they apply.
For full details, see Synvisc-One Official Site.
Who is a good candidate for Synvisc-One injections?
A good candidate for Synvisc-One is typically an adult with osteoarthritis (OA) of the knee who has not found enough relief from non-drug measures such as exercise, weight management or physical therapy, or from simple pain relievers. Because the product is given as a single injection intended to relieve knee pain for up to about six months, it may particularly suit people who want a long-lasting option without frequent dosing or daily medication.
It may also be considered by people who cannot take, or do not respond well to, other oral pain medicines, and by those who wish to delay or avoid knee replacement surgery. A clinician usually confirms the diagnosis, checks that the knee joint is suitable for injection, and reviews the person's medical history.
Synvisc-One is not for everyone. It is generally not recommended for people with active knee joint infection, some skin infections near the injection site, or known allergy to its components. Candidacy is a medical judgement, so anyone considering it should discuss symptoms, previous treatments and risks with a qualified healthcare professional. More background is available at Synvisc-One® Official Site.
How is Synvisc-One administered and is it covered by insurance?
How Synvisc-One is administered
Synvisc-One is a single-injection treatment for knee osteoarthritis, given by a healthcare professional. The injection is placed directly into the knee joint, so administration happens in a clinic or office setting rather than at home. Because it is a one-dose product, patients do not need a series of repeat visits for the injection itself, though follow-up care depends on the clinician’s judgment.
The official site presents it as an option for people seeking knee pain relief over an extended period, with the source describing up to six months of relief from a single injection. It is typically positioned for patients whose symptoms are not adequately managed by other approaches, and a doctor decides whether it is appropriate based on the joint and medical history.
Insurance coverage
The site does not state specific coverage details in the supplied information. In practice, insurance coverage for viscosupplementation varies by plan, insurer and country, and may require prior authorization or documentation of earlier treatments. Patients in the United States often check with their insurer or the clinic’s billing staff, while those elsewhere may find it handled differently or not covered at all.
For the manufacturer’s own framing, see Synvisc-One® Official Site.
User reviews (0)